Bioline RX (NASDAQ:BLRX) Given a $4.00 Price Target by HC Wainwright Analysts

Retrieved on: 2017-12-31 21:28:58

Tags for this article:

Business

Economy

Click the tags to see associated articles and topics

Bioline RX (NASDAQ:BLRX) Given a $4.00 Price Target by HC Wainwright Analysts. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC acquired a new stake in Bioline RX Ltd (NASDAQ:BLRX) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 131,480 shares of the biotechnology company's stock, valued ...</div>

Article found on:

View Original Article